Short answer
A positive RET result can mean different things depending on whether testing was done on blood or saliva as a germline hereditary result, or on tumor tissue as a cancer profiling result. A germline pathogenic RET variant can confirm MEN2 risk and may affect thyroid, adrenal, parathyroid, and family testing plans. The most useful next step is to get the exact variant and report type, then review it with genetics and the specialist team.
How to frame the result
| Result detail | Common next question | Why it matters |
|---|---|---|
| Germline RET pathogenic variant | Which codon and MEN2 risk category? | Variant-specific risk changes timing and surveillance. |
| RET found on tumor testing | Was germline confirmation recommended? | Tumor-only results do not always mean inherited risk. |
| Variant of uncertain significance | Was it clearly labeled uncertain? | A VUS should not be treated like a pathogenic family variant. |
What to do next
- Confirm whether the sample was blood, saliva, buccal swab, tumor tissue, or circulating tumor DNA.
- Write down the exact RET variant, including codon, transcript, and classification.
- Ask whether the report suggests MEN2A, MEN2B, familial medullary thyroid carcinoma, or another RET-related pattern.
- Review whether calcitonin, thyroid ultrasound, adrenal screening, calcium, or surgery timing changes now.
- Ask which relatives should be offered targeted testing and whether a genetics visit is needed first.
How to read results
| Result type | What it usually means | Next question |
|---|---|---|
| Positive for a known family RET variant | The person likely inherited the familial MEN2 risk. | What surveillance or preventive planning starts now? |
| Positive on tumor-only testing | May reflect a somatic cancer change rather than inherited risk. | Is germline confirmation needed? |
| VUS | Not a confirmed family-risk result. | Will the lab reclassify it later? |
| Positive RET plus medullary thyroid cancer | The report may be pointing to MEN2 evaluation. | Should the person and relatives be offered genetics and endocrine follow-up? |
When family history changes the next step
Follow-up matters more when a positive RET result could change family testing, childhood timing, or endocrine surveillance. Genetics counseling helps decide whether the result is pointing to MEN2 planning, tumor-only follow-up, or a family-variant question that needs targeted testing.
When specialist review matters
Specialist review matters when a positive result could change surgery timing, adrenal screening, or which relatives are tested first.
How genetic testing is done
Genetic testing is usually done with blood or saliva, and the lab workflow depends on whether the question is a targeted variant, a panel, or confirmation after a clinical finding. Genetics counseling can help clarify whether the next step is a new test, family testing, or a different clinical workup.
Questions to ask
- Was the sample blood, saliva, tumor, or another specimen?
- What is the exact RET variant, including codon and classification?
- Does the result change thyroid, calcitonin, pheochromocytoma, parathyroid, or surgery timing?
- Should relatives get targeted testing for the same family variant?
- Is this result being treated as germline, tumor-only, or uncertain?
- Who coordinates the next step if the result changes family management?
FAQ
Does a positive RET result always mean MEN2?
A germline pathogenic RET variant can strongly support MEN2 risk, but a RET finding on tumor testing alone does not automatically mean inherited MEN2.
What is the first thing to check on the report?
Check whether the sample was blood or saliva, or whether it came from tumor tissue, because that changes whether the result is about inherited risk or cancer profiling.
What does a positive family RET result usually trigger?
It usually triggers genetics review, MEN2-specific surveillance planning, and targeted testing for relatives who may carry the same variant.
Can a RET VUS be managed like a positive result?
Usually not. A VUS is uncertain and should not be treated like a confirmed pathogenic family variant unless the lab reclassifies it.
Why does codon and variant wording matter?
Different RET variants have different MEN2 risk levels and surveillance timing, so the exact codon and classification can change the next step.
Who should help explain the result?
Genetics and endocrine specialists usually help translate the report into a plan for the person tested and the rest of the family.